Trials / Completed
CompletedNCT00729911
Ablation vs Amiodarone for Treatment of AFib in Patients With CHF and an ICD
Ablation vs. Amiodarone for Treatment of Atrial Fibrillation in Patients With Congestive Heart Failure and an Implanted ICD/CRTD
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 203 (actual)
- Sponsor
- Texas Cardiac Arrhythmia Research Foundation · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
1. To determine if catheter-based atrial fibrillation (AF) ablation is superior to Amiodarone treatment for symptomatic persistent/permanent AF in ICD/CRTD patients with an impaired left ventricular function. 2. Hypothesis: AF ablation is better than Amiodarone for subjects with symptomatic persistent or permanent AF and impaired LV function in terms of recurrence of AF, quality of life, 6-minute walk distance, EF and total number of hospitalizations.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Atrial Fibrillation ablation | Radio-frequency catheter ablation of atrial fibrillation |
| DRUG | Amiodarone | Taken orally on a daily basis. |
Timeline
- Start date
- 2008-10-01
- Primary completion
- 2014-12-01
- Completion
- 2015-12-01
- First posted
- 2008-08-08
- Last updated
- 2019-04-10
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00729911. Inclusion in this directory is not an endorsement.